Elhaj Enaam T, Adam Ishag, Ahmed Mohamed A, Lutfi Mohamed F
Faculty of Applied Medical Science, Gezira University, Wad Madani, Sudan.
Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
BMC Physiol. 2016 Oct 31;16(1):5. doi: 10.1186/s12899-016-0025-0.
Trimester-specific reference ranges for T3, T4, and TSH need to be established in different communities. Neither Sudan nor other African countries have established trimester-specific reference ranges for TSH, free T3 (FT3), and free T4 (FT4) in healthy pregnant women. This study aimed to establish trimester-specific reference ranges for TSH, FT3, and FT4 in healthy pregnant Sudanese women.
We performed a longitudinal study, which included 63 women with singleton pregnancies who were followed since early pregnancy until the third trimester. The study was performed in Saad Abu-Alela Hospital, Khartoum, Sudan, during January to October 2014. An equal number of age- and parity-matched non-pregnant women were enrolled as a control group. Basic clinical and obstetrics data were gathered using questionnaires. TSH, FT3, and FT4 levels were measured. Median (5th-95th centile) values of TSH, FT3, and FT4 were 1.164 IU/ml (0.079-2.177 IU/ml), 4.639 nmol/l (3.843-6.562 nmol/l), and 16.86 pmol/l (13.02-31.48 pmol/l) in the first trimester. Median values of TSH, FT3, and FT4 were 1.364 IU/ml (0.540-2.521 IU/ml), 4.347 nmol/l (3.425-5.447 nmol/l), and 13.51 pmol/l (11.04-31.07 pmol/l) in the second trimester. These values were 1.445 IU/ml (0.588-2.460 IU/ml), 4.132 nmol/l (3.176-5.164 nmol/l), and 12.87 pmol/l (9.807-23.78 pmol/l) in the third trimester, respectively. TSH levels increased throughout the trimesters. FT3 and FT4 levels were significantly higher in the first trimester compared with the second and third trimesters. TSH, FT3, and FT4 levels were significantly lower in pregnant women compared with non-pregnant women (P < 0.001).
The present study is the first to establish trimester-specific reference ranges of TSH, FT3, and FT4 in Sudanese women with normal pregnancies. Our results suggest that pregnancy is likely to suppress TSH, T3, and T4 levels in healthy women.
不同社区需要建立孕早期、孕中期和孕晚期特异的T3、T4及促甲状腺激素(TSH)参考范围。苏丹及其他非洲国家均未建立健康孕妇孕早期、孕中期和孕晚期特异的促甲状腺激素、游离T3(FT3)及游离T4(FT4)参考范围。本研究旨在建立苏丹健康孕妇孕早期、孕中期和孕晚期特异的促甲状腺激素、FT3及FT4参考范围。
我们开展了一项纵向研究,纳入63名单胎妊娠女性,自孕早期至孕晚期进行随访。研究于2014年1月至10月在苏丹喀土穆的萨阿德·阿布-阿莱拉医院进行。选取数量相等、年龄和产次匹配的非孕女性作为对照组。通过问卷调查收集基本临床和产科数据。检测促甲状腺激素、FT3及FT4水平。孕早期促甲状腺激素、FT3及FT4的中位数(第5-95百分位数)分别为1.164 IU/ml(0.079-2.177 IU/ml)、4.639 nmol/l(3.843-6.562 nmol/l)及16.86 pmol/l(13.02-31.48 pmol/l)。孕中期促甲状腺激素、FT3及FT4的中位数分别为1.364 IU/ml(0.540-2.521 IU/ml)、4.347 nmol/l(3.425-5.447 nmol/l)及13.51 pmol/l(11.04-31.07 pmol/l)。孕晚期这些值分别为1.445 IU/ml(0.588-2.460 IU/ml)、4.132 nmol/l(3.176-5.164 nmol/l)及12.87 pmol/l(9.807-23.78 pmol/l)。促甲状腺激素水平在整个孕期升高。与孕中期和孕晚期相比,孕早期FT3和FT4水平显著更高。孕妇促甲状腺激素、FT3及FT4水平显著低于非孕女性(P<0.001)。
本研究首次建立了苏丹正常妊娠女性孕早期、孕中期和孕晚期特异的促甲状腺激素、FT3及FT4参考范围。我们的结果表明,妊娠可能会抑制健康女性的促甲状腺激素、T3和T4水平。